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ABSTRACT 
Objective To determine the incidence of type 2 diabetes in people with a history of 
hospitalisation for major mental illness versus no mental illness in Scotland, by time 
period and sociodemographics.  
Research design and methods We used national Scottish population-based 
records to create cohorts with a hospital record of schizophrenia, bipolar disorder or 
depression, or no mental illness and to ascertain diabetes incidence. We used quasi-
Poisson regression models including age, sex, time period and area-based 
deprivation to estimate incidence and relative risks (RRs) of diabetes by mental 
illness status. Estimates are illustrated for people aged 60 years and in the middle 
deprivation quintile in 2015. 
Results We identified 254,136 diabetes cases during 2001-2015. Diabetes 
incidence in 2015 was 1.5 to 2.5-fold higher in people with versus without a major 
mental disorder, with the gap having slightly increased over time. RRs of diabetes 
incidence were greater among women than men for schizophrenia (RR 2.40 [95% CI 
2.01, 2.85] and 1.63 [1.38, 1.94]), respectively) and depression (RR 2.10 [1.86, 2.36] 
and 1.62 [1.43, 1.82]), but similar for bipolar disorder (RR 1.65 [1.35, 2.02] and 1.50 
[1.22, 1.84]). Absolute and relative differences in diabetes incidence associated with 
mental illness increased with increasing deprivation.  
Conclusions: Disparities in diabetes incidence between people with and without 
major mental illness appear to be widening. Major mental illness has a greater effect 
on diabetes risk in women and people living in more deprived areas, which has 
implications for intervention strategies to reduce diabetes risk in this vulnerable 
population.  
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INTRODUCTION 
 
The life expectancy of people with major mental illness, including schizophrenia, 
bipolar disorder or major depressive disorder, is reduced by 10-20 years compared 
to the general population (1-3). This excess mortality is largely due to an increased 
risk of cardiovascular disease (3-6), for which type 2 diabetes mellitus is a major risk 
factor. Numerous studies have reported the higher prevalence of diabetes among 
those with a major mental disorder. Recent meta-analyses have demonstrated that, 
although estimates vary substantially across studies, the prevalence of type 2 
diabetes is about 10% in those with schizophrenia and bipolar disorder and about 
8% in those with major depressive disorder (7-10). This relates to about a two-fold 
increased prevalence of diabetes when compared to the general population after 
adjusting for age, and could extend to as much as a three- to four-fold excess risk in 
some sub-groups of the population. However, these estimates are almost entirely 
derived from cross-sectional studies, with few existing prospective studies on the 
incidence of diabetes in those with major mental illness. Where prospective studies 
have been carried out, these have focused far more on diabetes incidence among 
people with depression (11-13) than schizophrenia or bipolar disorder (14, 15).  
The association between major mental illness and diabetes is explained at least in 
part by key lifestyle factors such as body mass index which are known to be 
associated with mental illness and are also major risk factors for type 2 diabetes. 
The relationship between major mental illness and diabetes risk factors might vary 
with age, sex and socioeconomic status, providing the rationale for examining 
whether the association between major mental illness and subsequent diabetes 
might differ by sociodemographic factors. We know remarkably little about how the 
association between major mental disorder and diabetes incidence differs by these 
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sociodemographic factors. Meta-analyses have suggested that the association 
between depression in general and type 2 diabetes may be more marked in younger 
than older people (11), but this is derived from cross-study comparisons rather than 
investigation of age differences within the same study population. Also, the 
prevalence of co-morbid mental disorder and diabetes prevalence has been 
proposed to be higher in women than men (8, 16), again based on cross-sectional 
data, with few prospective studies reporting sex-specific associations of co-morbid 
mental disorder and diabetes. To our knowledge no study has prospectively 
examined how the association between mental illness and type 2 diabetes differs by 
socioeconomic status. Similarly, to our knowledge, there have been no studies of 
time trends in type 2 diabetes incidence by major mental illness status and so it is 
also unclear whether the difference in risk has narrowed or widened over time.  
Therefore, in the present study we examined incidence of type 2 diabetes in 
Scotland from 2001-2015 among those with a prior hospital record for major mental 
illness versus those without a history of hospitalisation for any mental health 
disorder, exploring differences by time period, age, sex and socioeconomic status. 
METHODS  
We used the dataset of the General Acute inpatient and Day Case - Scottish 
Morbidity Records (SMR01) and the Mental Health Inpatient and Day Case dataset 
(SMR04) to identify hospital admissions where the discharge diagnoses included 
schizophrenia (International Statistical Classification of Diseases [ICD] 10 F20 and 
F25 and ICD9 295.0 to 295.3, 295.6 to 295.9), bipolar disorder (ICD10 F30 to F31 
and ICD9 296.0 to 296.1, 296.4 to 296.7) or depression (ICD10 F32-F34 and ICD9 
296.2 to 296.3, 298.0, 311). We applied a hierarchy of severity to assign people to 
one group only, ranking disorders as schizophrenia, bipolar disorder and depression; 
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thus, someone with a record of both bipolar disorder and depression was assigned 
to the bipolar group only. Individuals entered the cohort from the date of first hospital 
admission for the most severe of the three disorders. We identified prevalent cases 
of mental health disorder among those aged 18 years or older between 1st January 
1981 and 31st December 2014. We initially carried out exploratory analyses to 
investigate whether associations differed for people with an uncomplicated mental 
illness (i.e. diagnosis of a single mental illness) and complex mental illness (i.e. 
diagnoses of multiple mental illnesses). The patterns of associations were broadly 
similar and so we did not stratify data in the final analyses. 
Comparison cohort 
Our comparison cohort was derived from the total general population, after removing 
people who had a hospital record for any mental illness listed in ICD10 chapter 5 
(mental and behavioural disorders) or the corresponding ICD9 codes, with the 
exception of organic disorders (F00-F09) and mental retardation (F70-F79). Details 
of the ICD codes used are provided in Supplementary Table S1.  
Type 2 diabetes  
We identified incident cases of type 2 diabetes through a research extract of the 
Scottish Care Information – Diabetes (SCI-Diabetes) dataset. This national diabetes 
register includes approximately 99% of all patients diagnosed with diabetes since 
2004 (17), collating information from primary and secondary care clinics on clinical 
care, demographic and lifestyle factors. It also includes information on people 
diagnosed with diabetes between 2001 and 2004 and who did not die during that 
time period. For research purposes, an algorithm is used to differentiate between 
type 1 and type 2 diabetes, based on clinician-recorded diagnosis, prescription data 
and age at diabetes diagnosis. In this study, we included all incident type 2 diabetes 
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cases occurring between 1st January 2001 and 31st December 2015   
Person-time 
We calculated person-time (in fractional years) for the mental health cohort from the 
date of hospital admission with a mental health disorder until the end date of follow 
up.  We followed the cohort until the earliest of type 2 diabetes diagnosis date, date 
of death, or end of follow-up (31st December 2015). We obtained person-time for the 
comparison population via mid-year estimates of the population. Person-time after 
an event was subtracted from the estimates in each year. 
Events and person-time were broken down by calendar year, age in 5-years 
categories, sex and area-based deprivation. The latter was defined using quintiles of 
the Carstairs Index, which uses census data at postcode level on lack of car 
ownership, low occupational social class, overcrowded households and male 
unemployment to create a measure of material deprivation of an area (18).  
Statistical analyses 
We summarised baseline characteristics for the complete cohort and calculated age-
standardised type 2 diabetes incidence rates, per 1000 person-years (pyrs), using 
the 2013 European Standard Population (see http://www.isdscotland.org/Products-
and-Services/GPD-Support/Population/Standard-Populations/ for more details). We 
fitted quasi-Poisson models with incidence of type 2 diabetes as the outcome, which 
included main effects for history of a mental illness, age, sex, time period and area-
based deprivation index and all two-way interactions. Age (using the mid-point of 
each 5-year block) and time period were modelled as continuous variables using 
natural cubic splines. Area-based deprivation index was modelled as a categorical 
variable. The models were used to calculate relative risks (RRs). All analyses were 
conducted using R software (19). 
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Ethics approval 
Approval for the linkage of the administrative health datasets used in this study was 
provided by the NHS Scotland Public Benefit and Privacy Panel for Health and 
Social Care. Approval for the use of diabetes data was obtained from the Scottish 
Diabetes Research Network and ethics approval was obtained from the South East 
Scotland Research Ethics Committee (reference 16/SS/0152). 
This article is written in accordance with the Strengthening Reporting of 
Observational Studies in Epidemiology (STROBE) (20) and Reporting of Studies 
Conducted using Observational Routinely-collected health data (RECORD) (21) 
statements. 
RESULTS 
Between 2001 and 2015 there were 246,046 incident type 2 diabetes mellitus cases 
in Scotland among people with no prior hospital record of a mental illness and 2315 
among those with a hospital record for schizophrenia, 1720 among those with bipolar 
disorder and 4055 among those with depression.  
Type 2 diabetes incidence by mental health status, age and sex 
Type 2 diabetes incidence increased with increasing age (until about 60 years) in all 
groups, but tended to peak at an earlier age among people with a mental disorder 
compared to those with no history of mental illness. Thus, the average age of type 2 
diabetes onset was lower in people with an admission for schizophrenia (mean 51.4 
years ± 12.6 SD) and depression (mean 57.6 ± 13.1 SD), but not bipolar disorder 
(mean 60.0 ± 12.1 SD) compared to the population with no mental illness (mean 
60.8 ± 13.2 SD; Supplementary Table S2). In all comparison groups, age of onset 
was slightly younger in men than women and in the most versus least deprived in all 
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groups. The age-standardised incidence of type 2 diabetes at all time points was 
higher among people with a hospital record for each mental disorder than the group 
without mental illness (Supplementary Table S3). This concurred with predicted 
incidence rates obtained from quasi-Poisson models, as illustrated in Figure 1, which 
shows type 2 diabetes incidence by age for the middle deprivation quintile, in 2001 
and 2015. Absolute rates of type 2 diabetes were higher in men than women in all 
cohorts, although the difference in incidence was smaller for people with 
schizophrenia and bipolar disorder (Figure 1).  
Time-trends in diabetes incidence by mental disorder 
Between 2001 and 2015, age-standardised type 2 diabetes incidence decreased 
overall in the group with no history of mental illness, in both men and women. Among 
those with schizophrenia and bipolar disorder, type 2 diabetes incidence increased 
between 2001 and 2008 and then started to decrease up to 2015. In contrast, 
incidence of type 2 diabetes increased between 2001 and 2015 among people with a 
hospital record for depression. These findings are illustrated in Figure 2 using data 
from men and women aged 60 years and in the middle deprivation quintile. We 
observed similar patterns of type 2 diabetes incidence among those aged 40 and 50 
years (especially for depression), although there was less of a decline in incidence in 
the cohort without mental illness compared to the 60 year-olds and diabetes 
incidence tended to plateau from 2008 onwards in people with schizophrenia and 
bipolar disorder (supplementary Figure 1). In general, having a hospital record for 
each mental disorder was associated with increased incidence of type 2 diabetes 
when compared to the group without mental illness. For example, in 2015, among 
men aged 60 years and in the middle deprivation quintile, type 2 diabetes incidence 
was higher in those with schizophrenia (RR 1.63, 95% CI 1.38 to 1.94), in men with 
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bipolar disorder (RR 1.50, 95% CI 1.22 to 1.84) and in men with depression (RR 
1.62, 95% CI 1.43 to 1.82), compared to the group with no mental illness (Figure 2 
and Supplementary Table S4). RRs were greater among women than men, with 
incidence of type 2 diabetes in 2015 almost two-and-a-half-fold higher in women with 
schizophrenia (RR 2.40, 95% CI 2.01 to 2.85), 65% higher in those with bipolar 
disorder (RR 1.65, 95% CI 1.35, to 2.02) and two-fold higher in those with 
depression (RR 2.10, 95% CI 1.86 to 2.36) compared to the group with no mental 
illness (Figure 2 and Supplementary Table S4). Among both men and women, RRs 
compared to the group without mental illness among those aged 60 years increased 
over time for the schizophrenia, depression and, to a lesser extent, bipolar disorder 
cohorts, (Figure 3 and Supplementary Table S4). RR estimates over time followed 
similar patterns at ages 40 and 50 years (Supplementary Figure 2). 
Type 2 diabetes incidence by mental disorder, sex and deprivation level 
The proportion of people in the most deprived quintile was much higher in the 
cohorts with schizophrenia (32.8%), bipolar disorder (27.0%) and depression 
(27.0%) than the comparison group (21.7%; Supplementary Table 2). Type 2 
diabetes incidence was positively associated with deprivation among women in all 
cohorts and men with a mental disorder, as illustrated in Figure 4. We did not 
observe a deprivation gradient in type 2 diabetes incidence among men without 
mental illness at 60 years of age, but did at age 40 years (supplementary Figure 3). 
For all disorders, the RR of type 2 diabetes incidence was greatest among people in 
the most deprived quintiles (Supplementary Table S5). For instance, in 2015 the RR 
for type 2 diabetes incidence in 60 year-old men with versus without schizophrenia in 
the most deprived quintile was 1.69 (95% CI 1.45 to 1.98) whereas in the association 
for men with versus without schizophrenia in the least deprived quintile was not 
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statistically significant (RR 1.09, 95% CI 0.88 to 1.36). A similar pattern was 
observed among men with bipolar disorder and depression. RRs for women were 
larger than men for all mental disorder groups. As with men, RRs were positively 
associated with deprivation, but in contrast to men, the association was statistically 
significant in the least deprived group. For example, schizophrenia was associated 
with a two-and-a-half-fold (RR 2.48, 95% CI 2.12 to 2.91) and a 60% (RR 1.60, 95% 
CI 1.28 to 2.01) increased risk of type 2 diabetes incidence in the most and least 
deprived quintiles, respectively (Supplementary Table S5). The larger relative risks in 
women than men are only partly due to lower absolute rates of diabetes in women 
than men, since we observed a greater difference in type 2 diabetes incidence 
among those with versus without schizophrenia (and to a lesser degree, depression) 
in women compared to men (Supplementary Figure 4). Therefore, having a hospital 
record for schizophrenia or depression is more strongly associated with incidence of 
type 2 diabetes in women than men in all deprivation groups, but particularly the 
most deprived groups. 
CONCLUSIONS 
Main findings 
In Scotland, having a hospital admission for major mental illness is associated with a 
one-and-a-half to two-and-a-half-fold higher risk of type 2 diabetes incidence, with 
relative risk for those with compared to those without mental illness appearing to 
have increased over the last 15 years. In people with a hospital admission for 
schizophrenia or depression, type 2 diabetes incidence occurs at a younger age 
compared to people without a hospital admission for major mental illness. We found 
important sociodemographic differences, with the absolute and relative effects of 
mental illness being stronger in women than men and in deprived sub-groups, 
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indicating a greater impact of mental illness on type 2 diabetes risk in women and in 
people living in more deprived areas.  
Strengths and limitations 
To our knowledge, this is the first study to examine time trends in type 2 diabetes 
incidence by mental health disorder status, the first to examine differences in 
incidence by socioeconomic status and one of the first to investigate whether the 
prospective association differs by age and sex. Other strengths include the objective 
ascertainment of a diagnosis of type 2 diabetes, which was more than 99% complete 
from 2004 onwards, being based on a national diabetes register which collates 
information from primary care and secondary care clinics. The national scale and 
long-term running of the diabetes register also led to the inclusion of large numbers 
of diabetes cases, thus facilitating the investigation of interaction by time, age, sex 
and socioeconomic status.  
Our study does however have some shortcomings. The main limitation is that, in the 
absence of national primary care data for research purposes, our definitions of major 
mental disorders were based on hospital records only. Therefore our findings may 
not be generalizable to those with a mental disorder who have never had their 
disorder recorded in hospital. This limitation is mitigated by the fact that hospital 
records extend as far back as 1981. Since we used both psychiatric and general 
hospital admission records to identify people with depression, there may have been 
selection bias in that people with less severe depression may have been included 
purely because they were admitted to a general hospital for an unrelated 
disease/episode. It is difficult to speculate how the definition of depression might 
have affected the results, since it could have both over-estimated the association 
between depression and diabetes (if a dose-response relationship exists between 
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depression and diabetes risk) or have under-estimated the association since people 
with depression that has not been recorded in hospital would not have been 
identified. Also, it is possible that those with a major mental disorder and admitted to 
hospital would be more likely to have their diabetes diagnosed, purely through 
having more contact with the health service. Also, we were not able to identify 
whether the associations differed depending on whether the mental illness diagnosis 
was recorded from psychiatric or acute hospital medical records; it would be of 
interest to explore this in future research. Finally, we were unable to adjust for factors 
known to be associated with mental illness and to be major risk factors for type 2 
diabetes, such as use of psychotropic medications, sleep disruption, low physical 
activity and poor dietary choices that influence BMI, the key risk factor for type 2 
diabetes. However, given that BMI may lie on the causal pathway between mental 
illness and type 2 diabetes, one could argue that minimally adjusted estimates more 
accurately convey the associated risk of diabetes.  
Interpretation in context of previous studies 
Despite the limitations of our study, our findings are consistent with previous 
prospective studies on the association between major mental disorders and type 2 
diabetes incidence. In general, cohort studies have found that depression is 
associated with a 30-100% increased risk of type 2 diabetes prior to adjustment for 
lifestyle factors (11-13) and schizophrenia and bipolar disorder with a 70-80% 
increased risk of type 2 diabetes (14).  
The slight decline in type 2 diabetes incidence observed among those with no 
hospital record for mental illness in our study is in line with overall trends in diabetes 
incidence in the general Scottish population (22). Since 2004, type 2 diabetes 
incidence in Scotland has declined or stabilised, depending on sex, age and 
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socioeconomic status, which is thought to be attributed to stabilising obesity 
prevalence and intensified diagnosis of type 2 diabetes leading to a smaller number 
and proportion of undiagnosed type 2 diabetes cases (22). However, our study 
demonstrates that this stabilisation or decline in type 2 diabetes incidence has not 
been observed among people with major mental illness. The link between major 
mental illness and excess risk of type 2 diabetes in people with a major mental 
disorder are multi-factorial and complex. Contributing factors include environmental, 
genetic and lifestyle factors. Drug treatment may also play a role, with antipsychotic 
and anti-depressant medication having been linked to type 2 diabetes via weight 
gain and other metabolic abnormalities(23, 24). Furthermore, mental illness itself 
may have a direct physiological effect. For instance, there is growing evidence of 
glucose homeostasis disruption among anti-psychotic-naïve individuals presenting 
with first episode schizophrenia (25).  Many mechanisms ultimately increase risk of 
obesity, the key risk factor for type 2 diabetes. The apparent increase in diabetes 
incidence over time among those with a major mental illness in our study could be 
due to a number of factors, including improved diabetes diagnosis in this group over 
time. Primary care screening for cardiometabolic disease in general and among 
people with mental illness was incentivised through the Quality and Outcomes 
Framework, a pay-for-performance scheme for general practitioners, which was in 
place in Scotland between 2004 and April 2017 (26). This offered a financial reward 
to promote good practice against a set of evidence-based indicators, including 
monitoring of cardiometabolic risk in people with mental illness. The increase in type 
2 diabetes incidence among those with a schziophrenia might also reflect the 
introduction, and more widespread use, of second generation antipsychotics, which, 
compared to first generation antipsychotics are thought to be associated with a 
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slightly higher increased risk of type 2 diabetes, via weight gain or effects on insulin 
resistance (27). However, it has been shown that all antipsychotics are associated 
with weight gain, albeit to varying degrees (28).  
The observed sex differences in our study are interesting. A systematic review of 
studies found no sex difference in type 2 diabetes prevalence in people with and 
without bipolar disorder, which is in line with our findings on incidence (9). A later 
review by the same authors pooled together studies of patients with schizophrenia, 
bipolar disorder and major depression and found that prevalence of diabetes was 
about 40% higher in women than men (8), but since the analyses combined all 
mental disorders, it is unclear how sex differences might have differed by mental 
disorder. Consistent with our findings on depression, a recent prospective study 
reported greater effects of depression on type 2 diabetes risk in women than men 
(29). One explanation for our findings could be the higher prevalence of obesity in 
women with these mental health disorders compared to men and the larger relative 
gap in obesity between those with and without mental illness in women compared to 
men (30). It is intriguing that we did not observe similarly pronounced sex differences 
in the bipolar disorder group, given similar patterns of obesity by sex in this group.  
As with sex, previous studies have tended to adjust for socioeconomic status, rather 
than investigate potential interactions between mental disorders and socioeconomic 
status. Our findings indicate that, for all mental health disorders, the absolute and 
relative difference in diabetes rates are exacerbated by increasing level of 
deprivation, highlighting the additional vulnerability of people with a mental illness 
who live in deprived areas. Previous Scottish studies have found that the excess 
mortality associated with severe mental illness is most marked in the most deprived 
population groups (31), and that multimorbidity, including mental-physical health 
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comorbidity is more prevalent among more deprived groups (32). By demonstrating 
that the association between mental disorder and type 2 diabetes varies markedly by 
deprivation level, our study suggests that this increased diabetes risk is due largely 
to modifiable factors rather than intrinsic physiological effects of the mental illness 
itself.  
Implications 
The temporal and sociodemographic variations in the association between major 
mental disorders and diabetes have important implications for both clinical care and 
intervention strategies aimed at equitable improvement of physical health in people 
with mental illness. Sex and socioeconomic differences highlight the particularly high 
increased risk of type 2 diabetes among women and people living in more deprived 
areas with a mental illness. Reasons for these variations are likely multi-factorial and 
should be investigated further in future studies. Higher prevalence of obesity in 
women compared to men with mental illness could account for some of the observed 
sex differences in the association between mental illness and type 2 diabetes 
incidence. The importance of monitoring and attempting to improve the 
cardiometabolic health of people with major mental illness (and in particular, women 
and people with a low socioeconomic status) should continue to be emphasised to 
psychiatrists and primary care physicians. Novel intervention approaches aimed at 
reducing type 2 diabetes risk in people with mental illness should be tailored 
accordingly and involve targeted as well as universal strategies. Factors related to 
both socioeconomic status and mental illness, and amenable to intervention, include 
provision of care (33), health literacy (34), engagement with health services (35) and 
lifestyle behaviour. Whilst improvement of each of these is undoubtedly challenging, 
these must all be tackled if we are to reduce the risk of type 2 diabetes in people with 
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mental illness, particularly in more deprived areas. Furthermore, more pharmaco-
epidemiological studies are urgently needed to improve our understanding of the 
potential adverse metabolic consequences of antipsychotics, mood stabilisers and 
anti-depressants. In an era of precision medicine, advances in the refined tailoring of 
psychotropic drug prescribing practices to optimise control of mental health 
symptoms and minimise side-effects on physical health may be possible in the 
future.        
Conclusion 
In Scotland, major mental illness is associated with a marked increased risk of 
incidence of type 2 diabetes, with evidence of increasing disparities in the last 15 
years. The absolute and relative effects of mental illness are stronger in women than 
men and in more deprived sub-groups. These findings provide important insights into 
temporal and sociodemographic differences in type 2 diabetes risk across multiple 
mental health disorders, which have implications for clinical care and intervention 
strategies.    
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FIGURE LEGENDS 
Figure 1 Type 2 diabetes incidence* among people in the middle deprivation quintile, 
for 2001 and 2015, by age, type or absence of mental disorder and sex 
*Predicted incidence rates obtained from quasi-Poisson regression models including mental health status, age, sex, 
deprivation and time period, plus all mental health status and age interactions 
 
Figure 2 Predicted type 2 diabetes incidence* among people aged 60 years and in 
the middle deprivation quintile by mental disorder, sex and year 
*Predicted incidence rates obtained from quasi-Poisson regression models including mental health status, age, sex, 
deprivation and time period, plus all mental health status and age interactions 
 
Figure 3 Relative risks of type 2 diabetes incidence among those with a hospital 
record for each mental disorder versus no mental illness, by sex, illustrated for 
people aged 60 years and in the middle deprivation quintile in 2015 
 
Figure 4 Predicted diabetes incidence* by quintiles of area-based deprivation for 
each mental disorder, by sex, among people aged 60, in 2015 
*Predicted incidence rates obtained from quasi-Poisson regression models including mental health status, age, sex, 
deprivation and time period, plus all mental health status and age interactions 
 
